Article Details

Seres Therapeutics (NASDAQ:MCRB) Rating Lowered to Sell at BidaskClub

Retrieved on: 2019-05-12 20:33:45

Tags for this article:

Click the tags to see associated articles and topics

Seres Therapeutics (NASDAQ:MCRB) Rating Lowered to Sell at BidaskClub. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new stake in Seres Therapeutics in the fourth quarter valued at about $82,000. DekaBank Deutsche Girozentrale ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo